ABO blood type, long-standing diabetes, and the risk of pancreatic cancer.

ABSTRACT:

Aim

To retrospectively study pancreatic cancer patients with respect to their ABO blood type and diabetes.

Methods

Our analysis included a cohort of 1017 patients with pancreatic ductal cancer diagnosed at our hospital in Tokyo. They were divided into two groups: 114 patients with long-standing type 2 diabetes (DM group, defined as diabetes lasting for at least three years before the diagnosis of pancreatic cancer) and 903 patients without diabetes (non-DM group). Multivariate analysis was performed to identify factors that are associated with long-standing diabetes. The DM group was further divided into three subgroups according to the duration of diabetes (3-5 years, 5.1-14.9 years, and 15 years or more) and univariate analyses were performed.

Results

Of the 883 pan

SUBMITTER: Egawa N 

PROVIDER: S-EPMC3646145 | biostudies-literature | 2013 Apr

REPOSITORIES: biostudies-literature